Found 22756 hits with Last Name = 'ye' and Initial = 'd' Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kJ/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Oxidized purine nucleoside triphosphate hydrolase
(Homo sapiens (Human)) | BDBM50511450
(CHEMBL4436749)Show InChI InChI=1S/C18H21N3O/c1-11-6-4-7-14(12(11)2)18-15-8-5-9-19-16(15)10-17(21-18)20-13(3)22/h4,6-7,10,19H,5,8-9H2,1-3H3,(H,20,21,22) | PDB
UniProtKB/SwissProt
GoogleScholar
AffyNet 
| PC cid
PC sid
PDB
UniChem
| PDB
Article
PubMed
| 0.00200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc.
Curated by ChEMBL
| Assay Description
Reversible inhibition of human recombinant human His-tagged MTH1 expressed in Escherichia coli BL21 (DE3) using 8-oxo-dGTP as substrate incubated for... |
ACS Med Chem Lett 11: 358-364 (2020)
Article DOI: 10.1021/acsmedchemlett.9b00420
BindingDB Entry DOI: 10.7270/Q2PV6PPZ |
More data for this
Ligand-Target Pair | 
3D Structure (crystal) |
Oxidized purine nucleoside triphosphate hydrolase
(Homo sapiens (Human)) | BDBM50511450
(CHEMBL4436749)Show InChI InChI=1S/C18H21N3O/c1-11-6-4-7-14(12(11)2)18-15-8-5-9-19-16(15)10-17(21-18)20-13(3)22/h4,6-7,10,19H,5,8-9H2,1-3H3,(H,20,21,22) | PDB
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
PDB
UniChem
| PDB
Article
PubMed
| 0.00200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gilead Sciences, Inc.
Curated by ChEMBL
| Assay Description
Reversible inhibition of human recombinant human His-tagged MTH1 expressed in Escherichia coli BL21 (DE3) using 8-oxo-dGTP as substrate incubated for... |
ACS Med Chem Lett 11: 358-364 (2020)
Article DOI: 10.1021/acsmedchemlett.9b00420
BindingDB Entry DOI: 10.7270/Q2PV6PPZ |
More data for this
Ligand-Target Pair |
3D Structure (crystal) |
Calcitonin gene-related peptide type 1 receptor/Receptor activity-modifying protein 1
(Homo sapiens (Human)) | BDBM50184069
(CHEMBL207197 | N-((R)-1-((S)-6-amino-1-oxo-1-(4-(p...)Show SMILES NCCCC[C@H](NC(=O)[C@@H](Cc1cc(Br)c(O)c(Br)c1)NC(=O)N1CCC(CC1)N1Cc2ccccc2NC1=O)C(=O)N1CCN(CC1)c1ccncc1 Show InChI InChI=1S/C38H47Br2N9O5/c39-29-21-25(22-30(40)34(29)50)23-33(45-37(53)48-15-10-28(11-16-48)49-24-26-5-1-2-6-31(26)44-38(49)54)35(51)43-32(7-3-4-12-41)36(52)47-19-17-46(18-20-47)27-8-13-42-14-9-27/h1-2,5-6,8-9,13-14,21-22,28,32-33,50H,3-4,7,10-12,15-20,23-24,41H2,(H,43,51)(H,44,54)(H,45,53)/t32-,33+/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
antibodypedia
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
MCE
PC cid
PC sid
PDB
UniChem
Patents
Similars
| PDB
Article
PubMed
| 0.00500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Department of Medicinal Chemistry Merck & Co.
Curated by ChEMBL
| Assay Description
Displacement of [125I]CGRP from human cloned CLR/RAMP1 receptor expressed in E10 cells |
Bioorg Med Chem Lett 16: 2595-8 (2006)
Article DOI: 10.1016/j.bmcl.2006.02.051
BindingDB Entry DOI: 10.7270/Q2HT2NX8 |
More data for this
Ligand-Target Pair |
3D Structure (crystal) |
Somatostatin receptor type 5
(RAT) | BDBM82463
(Cyclo[L-Trp-D-Trp-L-Lys-L-Thr-L-Phe-(7-amino*hepta...)Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)CCCCCCNC(=O)[C@H](Cc2ccccc2)NC1=O Show InChI InChI=1S/C57H70N10O8/c1-36(68)51-57(75)66-46(30-37-18-6-4-7-19-37)52(70)59-29-17-3-2-10-27-50(69)62-47(31-38-20-8-5-9-21-38)54(72)64-49(33-40-35-61-44-25-14-12-23-42(40)44)56(74)65-48(32-39-34-60-43-24-13-11-22-41(39)43)55(73)63-45(53(71)67-51)26-15-16-28-58/h4-9,11-14,18-25,34-36,45-49,51,60-61,68H,2-3,10,15-17,26-33,58H2,1H3,(H,59,70)(H,62,69)(H,63,73)(H,64,72)(H,65,74)(H,66,75)(H,67,71)/t36-,45+,46+,47+,48-,49+,51+/m1/s1 | UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sandoz Pharma Ltd.
Curated by PDSP Ki Database
| |
Naunyn Schmiedebergs Arch Pharmacol 350: 441-53 (1994)
Article DOI: 10.1007/BF00173012
BindingDB Entry DOI: 10.7270/Q2XD105R |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 2
(MOUSE) | BDBM82469
(BIM 23003 | BIM-23003 | EC5-21 | L-Cys(1)-L-Lys-L-...)Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc2ccccc2)NC1=O)[C@@H](C)O)C(O)=O Show InChI InChI=1S/C71H95ClN16O17S2/c1-38(90)58-69(102)84-52(30-41-17-7-4-8-18-41)67(100)88-59(39(2)91)70(103)85-55(35-89)68(101)86-56(71(104)105)37-107-106-36-46(75)60(93)78-48(21-11-13-27-73)61(94)83-54(33-57(76)92)66(99)81-51(31-42-23-25-44(72)26-24-42)63(96)80-50(29-40-15-5-3-6-16-40)64(97)82-53(32-43-34-77-47-20-10-9-19-45(43)47)65(98)79-49(62(95)87-58)22-12-14-28-74/h3-10,15-20,23-26,34,38-39,46,48-56,58-59,77,89-91H,11-14,21-22,27-33,35-37,73-75H2,1-2H3,(H2,76,92)(H,78,93)(H,79,98)(H,80,96)(H,81,99)(H,82,97)(H,83,94)(H,84,102)(H,85,103)(H,86,101)(H,87,95)(H,88,100)(H,104,105)/t38-,39-,46+,48+,49+,50+,51+,52+,53-,54+,55+,56+,58+,59+/m1/s1 | PDB
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sandoz Pharma Ltd.
Curated by PDSP Ki Database
| |
Naunyn Schmiedebergs Arch Pharmacol 350: 441-53 (1994)
Article DOI: 10.1007/BF00173012
BindingDB Entry DOI: 10.7270/Q2XD105R |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 2
(MOUSE) | BDBM82462
(BIM 23059 | D-Nal-c[Cys-Tyr-D-Trp-Lys-Thr-Cys]-Thr...)Show SMILES CC(CO)C(NC(=O)C1NC(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N[C@H](Cc2c[nH]c3ccccc23)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)CO)C(=O)NC(SS1)C(=O)N[C@@H](Cc1ccc2ccccc2c1)C(N)=O)C(N)=O |r| Show InChI InChI=1S/C54H68N12O12S2/c1-28(26-67)42(45(57)71)63-51(77)53-66-54(78)62-40(22-30-15-18-35(69)19-16-30)47(73)61-41(24-34-25-58-37-12-6-5-11-36(34)37)48(74)59-38(13-7-8-20-55)46(72)64-43(29(2)27-68)49(75)65-52(79-80-53)50(76)60-39(44(56)70)23-31-14-17-32-9-3-4-10-33(32)21-31/h3-6,9-12,14-19,21,25,28-29,38-43,52-53,58,67-69H,7-8,13,20,22-24,26-27,55H2,1-2H3,(H2,56,70)(H2,57,71)(H,59,74)(H,60,76)(H,61,73)(H,63,77)(H,64,72)(H,65,75)(H2,62,66,78)/t28?,29?,38-,39-,40-,41+,42?,43-,52?,53?/m0/s1 | PDB
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sandoz Pharma Ltd.
Curated by PDSP Ki Database
| |
Naunyn Schmiedebergs Arch Pharmacol 350: 441-53 (1994)
Article DOI: 10.1007/BF00173012
BindingDB Entry DOI: 10.7270/Q2XD105R |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 3
(MOUSE) | BDBM82256
(BIM 23056 | CAS_150155-61-6 | D-Phe-Phe-Tyr-D-Trp-...)Show SMILES CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](Cc1ccc2ccccc2c1)C(N)=O |r| Show InChI InChI=1S/C71H81N11O9/c1-44(2)63(71(91)81-61(39-47-22-10-5-11-23-47)67(87)77-58(64(74)84)41-49-29-32-50-24-12-13-25-51(50)36-49)82-66(86)57(28-16-17-35-72)76-70(90)62(42-52-43-75-56-27-15-14-26-54(52)56)80-69(89)60(40-48-30-33-53(83)34-31-48)79-68(88)59(38-46-20-8-4-9-21-46)78-65(85)55(73)37-45-18-6-3-7-19-45/h3-15,18-27,29-34,36,43-44,55,57-63,75,83H,16-17,28,35,37-42,72-73H2,1-2H3,(H2,74,84)(H,76,90)(H,77,87)(H,78,85)(H,79,88)(H,80,89)(H,81,91)(H,82,86)/t55-,57+,58-,59+,60+,61+,62-,63+/m1/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| Purchase
MCE
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| 0.0100 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sandoz Pharma Ltd.
Curated by PDSP Ki Database
| |
Naunyn Schmiedebergs Arch Pharmacol 350: 441-53 (1994)
Article DOI: 10.1007/BF00173012
BindingDB Entry DOI: 10.7270/Q2XD105R |
More data for this
Ligand-Target Pair | |
Neuronal acetylcholine receptor subunit alpha-4
(Homo sapiens (Human)) | BDBM50049757
(()-2-(6-Chloro-pyridin-3-yl)-7-aza-bicyclo[2.2.1]h...)Show InChI InChI=1S/C11H13ClN2/c12-11-4-1-7(6-13-11)9-5-8-2-3-10(9)14-8/h1,4,6,8-10,14H,2-3,5H2 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
PC cid
PC sid
PDB
UniChem
Patents
Similars
| Article
PubMed
| 0.0120 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Barrow Neurological Institute
Curated by PDSP Ki Database
| |
Mol Pharmacol 64: 1283-94 (2003)
Article DOI: 10.1124/mol.64.6.1283
BindingDB Entry DOI: 10.7270/Q2GF0S2V |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 2
(Homo sapiens (Human)) | BDBM50051568
((3S,6S,9S,12R,15S,18S)-9-(4-Amino-butyl)-3-benzyl-...)Show SMILES CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc2ccccc2)NC1=O Show InChI InChI=1S/C44H56N8O7/c1-26(2)38-43(58)50-37(23-28-12-6-5-7-13-28)44(59)52(4)27(3)39(54)48-35(22-29-17-19-31(53)20-18-29)41(56)49-36(24-30-25-46-33-15-9-8-14-32(30)33)42(57)47-34(40(55)51-38)16-10-11-21-45/h5-9,12-15,17-20,25-27,34-38,46,53H,10-11,16,21-24,45H2,1-4H3,(H,47,57)(H,48,54)(H,49,56)(H,50,58)(H,51,55)/t27-,34-,35-,36+,37-,38-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0200 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharma
Curated by PDSP Ki Database
| |
Eur J Pharmacol 348: 311-20 (1998)
Article DOI: 10.1016/s0014-2999(98)00159-9
BindingDB Entry DOI: 10.7270/Q2MK6BF9 |
More data for this
Ligand-Target Pair | |
Neuronal acetylcholine receptor subunit alpha-7
(Rattus norvegicus (Rat)) | BDBM50364856
(CHEMBL1950167)Show SMILES O=S1(=O)c2ccccc2-c2ccc(cc12)N1CCN2CCC1CC2 |(9.73,-11.78,;8.95,-13.11,;8.19,-11.77,;7.7,-14.01,;6.2,-13.68,;5.16,-14.83,;5.64,-16.29,;7.13,-16.62,;8.17,-15.48,;9.71,-15.48,;10.72,-16.64,;12.24,-16.34,;12.73,-14.89,;11.72,-13.72,;10.21,-14.03,;14.25,-14.59,;15.21,-15.86,;16.72,-15.87,;17.72,-14.73,;17.48,-13.28,;16.07,-12.5,;14.65,-13.09,;15.41,-14.42,;16.75,-13.64,)| Show InChI InChI=1S/C19H20N2O2S/c22-24(23)18-4-2-1-3-16(18)17-6-5-15(13-19(17)24)21-12-11-20-9-7-14(21)8-10-20/h1-6,13-14H,7-12H2 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0230 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [3H]methyllylcaconitine from alpha7 nAChR in rat brain |
Bioorg Med Chem Lett 22: 1633-8 (2012)
Article DOI: 10.1016/j.bmcl.2011.12.126
BindingDB Entry DOI: 10.7270/Q2D21Z2W |
More data for this
Ligand-Target Pair | |
Alpha-1A adrenergic receptor
(Homo sapiens (Human)) | BDBM50060964
((R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-...)Show SMILES CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(c1)S(N)(=O)=O Show InChI InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
DrugBank
MCE
KEGG
PC cid
PC sid
PDB
UniChem
Patents
Similars
| DrugBank
Article
PubMed
| 0.0290 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 300: 478-86 (2002)
Article DOI: 10.1124/jpet.300.2.478
BindingDB Entry DOI: 10.7270/Q2HX1B77 |
More data for this
Ligand-Target Pair | |
Alpha-1A adrenergic receptor
(Homo sapiens (Human)) | BDBM50060964
((R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-...)Show SMILES CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(c1)S(N)(=O)=O Show InChI InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1 | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
DrugBank
MCE
KEGG
PC cid
PC sid
PDB
UniChem
Patents
Similars
| DrugBank
Article
PubMed
| 0.0290 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description
Binding affinity against human adrenergic receptor subtype Alpha-1A adrenergic receptor using [3H]-prazosin as radioligand |
J Med Chem 40: 3141-3 (1997)
Article DOI: 10.1021/jm970364a
BindingDB Entry DOI: 10.7270/Q2R78DBB |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 3
(MOUSE) | BDBM82459
(BIM 23058 | BIM-23058 | D-Phe-L-Phe-L-Tyr-D-Trp-L-...)Show SMILES CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](N)Cc1ccccc1)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H]([C@@H](C)O)C(N)=O Show InChI InChI=1S/C62H77N11O10/c1-37(2)53(62(83)71-51(33-41-21-11-6-12-22-41)61(82)73-54(38(3)74)55(65)76)72-57(78)48(25-15-16-30-63)67-60(81)52(35-43-36-66-47-24-14-13-23-45(43)47)70-59(80)50(34-42-26-28-44(75)29-27-42)69-58(79)49(32-40-19-9-5-10-20-40)68-56(77)46(64)31-39-17-7-4-8-18-39/h4-14,17-24,26-29,36-38,46,48-54,66,74-75H,15-16,25,30-35,63-64H2,1-3H3,(H2,65,76)(H,67,81)(H,68,77)(H,69,79)(H,70,80)(H,71,83)(H,72,78)(H,73,82)/t38-,46-,48+,49+,50+,51+,52-,53+,54+/m1/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sandoz Pharma Ltd.
Curated by PDSP Ki Database
| |
Naunyn Schmiedebergs Arch Pharmacol 350: 441-53 (1994)
Article DOI: 10.1007/BF00173012
BindingDB Entry DOI: 10.7270/Q2XD105R |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 2
(Homo sapiens (Human)) | BDBM81767
(15-28-Somatostatin-28 | CAS_38916-34-6 | CB6417646...)Show SMILES C[C@@H](O)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CSSC[C@H](NC(=O)[C@H](CO)NC1=O)C(O)=O)NC(=O)CNC(=O)[C@H](C)N)[C@@H](C)O |r| Show InChI InChI=1S/C76H104N18O19S2/c1-41(79)64(100)82-37-61(99)83-58-39-114-115-40-59(76(112)113)92-72(108)57(38-95)91-75(111)63(43(3)97)94-71(107)54(33-46-23-11-6-12-24-46)90-74(110)62(42(2)96)93-66(102)51(28-16-18-30-78)84-69(105)55(34-47-36-81-49-26-14-13-25-48(47)49)88-68(104)53(32-45-21-9-5-10-22-45)86-67(103)52(31-44-19-7-4-8-20-44)87-70(106)56(35-60(80)98)89-65(101)50(85-73(58)109)27-15-17-29-77/h4-14,19-26,36,41-43,50-59,62-63,81,95-97H,15-18,27-35,37-40,77-79H2,1-3H3,(H2,80,98)(H,82,100)(H,83,99)(H,84,105)(H,85,109)(H,86,103)(H,87,106)(H,88,104)(H,89,101)(H,90,110)(H,91,111)(H,92,108)(H,93,102)(H,94,107)(H,112,113)/t41-,42+,43+,50-,51-,52-,53-,54-,55-,56-,57-,58-,59-,62-,63-/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
MCE
KEGG
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharma
Curated by PDSP Ki Database
| |
Eur J Pharmacol 348: 311-20 (1998)
Article DOI: 10.1016/s0014-2999(98)00159-9
BindingDB Entry DOI: 10.7270/Q2MK6BF9 |
More data for this
Ligand-Target Pair | |
Alpha-1A adrenergic receptor
(Rattus norvegicus (Rat)) | BDBM50060964
((R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-...)Show SMILES CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(c1)S(N)(=O)=O Show InChI InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1 | PDB
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| Purchase
CHEMBL
DrugBank
MCE
KEGG
PC cid
PC sid
PDB
UniChem
Patents
Similars
| PubMed
| 0.0300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description
In vitro binding affinity using [3H]-prazosin as radioligand against adrenoceptor alpha 1A |
J Med Chem 43: 1586-603 (2000)
BindingDB Entry DOI: 10.7270/Q29C6WNR |
More data for this
Ligand-Target Pair | |
Neuronal acetylcholine receptor subunit alpha-4
(Rattus norvegicus (Rat)) | BDBM50279404
(CHEMBL447388 | cis-2-(5-Ethoxy-3-pyridinyl)octahyd...)Show InChI InChI=1S/C13H19N3O/c1-2-17-13-3-12(6-15-7-13)16-8-10-4-14-5-11(10)9-16/h3,6-7,10-11,14H,2,4-5,8-9H2,1H3/t10-,11+ | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0350 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [3H]cytisine from alpha4beta2 nicotinic acetylcholine receptor in rat brain minus cerebellum membrane |
J Med Chem 52: 4126-41 (2009)
Article DOI: 10.1021/jm900249k
BindingDB Entry DOI: 10.7270/Q2GT5P3R |
More data for this
Ligand-Target Pair | |
Calcitonin gene-related peptide type 1 receptor
(Homo sapiens (Human)) | BDBM50342639
(CHEMBL1770729 | N-((6S,9R)-6-(2,3-difluorophenyl)-...)Show SMILES CC1(CCCO1)c1cnc2[C@@H](CC[C@H](Cn12)c1cccc(F)c1F)NC(=O)N1CCC2(CC1)OC(=O)Nc1ncccc21 |r| Show InChI InChI=1S/C31H34F2N6O4/c1-30(10-4-16-42-30)24-17-35-27-23(9-8-19(18-39(24)27)20-5-2-7-22(32)25(20)33)36-28(40)38-14-11-31(12-15-38)21-6-3-13-34-26(21)37-29(41)43-31/h2-3,5-7,13,17,19,23H,4,8-12,14-16,18H2,1H3,(H,36,40)(H,34,37,41)/t19-,23-,30?/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| 0.0360 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [125I]-CGRP from human recombinant CGRP receptor |
Bioorg Med Chem Lett 21: 2683-6 (2011)
Article DOI: 10.1016/j.bmcl.2010.12.054
BindingDB Entry DOI: 10.7270/Q2VM4CK8 |
More data for this
Ligand-Target Pair | |
Calcitonin gene-related peptide type 1 receptor
(Homo sapiens (Human)) | BDBM50342638
(CHEMBL1770728 | N-((6S,9R)-6-(2,3-difluorophenyl)-...)Show SMILES CCC(CC)(OC)c1cnc2[C@@H](CC[C@H](Cn12)c1cccc(F)c1F)NC(=O)N1CCC2(CC1)OC(=O)Nc1ncccc21 |r| Show InChI InChI=1S/C32H38F2N6O4/c1-4-31(5-2,43-3)25-18-36-28-24(12-11-20(19-40(25)28)21-8-6-10-23(33)26(21)34)37-29(41)39-16-13-32(14-17-39)22-9-7-15-35-27(22)38-30(42)44-32/h6-10,15,18,20,24H,4-5,11-14,16-17,19H2,1-3H3,(H,37,41)(H,35,38,42)/t20-,24-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| 0.0390 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [125I]-CGRP from human recombinant CGRP receptor |
Bioorg Med Chem Lett 21: 2683-6 (2011)
Article DOI: 10.1016/j.bmcl.2010.12.054
BindingDB Entry DOI: 10.7270/Q2VM4CK8 |
More data for this
Ligand-Target Pair | |
Calcitonin gene-related peptide type 1 receptor
(Homo sapiens (Human)) | BDBM50342625
(CHEMBL1770715 | N-((6S,9R)-6-(2,3-difluorophenyl)-...)Show SMILES COC(C)(C)c1cnc2[C@@H](CC[C@H](Cn12)c1cccc(F)c1F)NC(=O)N1CCC(CC1)n1c2cccnc2[nH]c1=O |r| Show InChI InChI=1S/C30H35F2N7O3/c1-30(2,42-3)24-16-34-27-22(10-9-18(17-38(24)27)20-6-4-7-21(31)25(20)32)35-28(40)37-14-11-19(12-15-37)39-23-8-5-13-33-26(23)36-29(39)41/h4-8,13,16,18-19,22H,9-12,14-15,17H2,1-3H3,(H,35,40)(H,33,36,41)/t18-,22-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| 0.0400 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [125I]-CGRP from human recombinant CGRP receptor |
Bioorg Med Chem Lett 21: 2683-6 (2011)
Article DOI: 10.1016/j.bmcl.2010.12.054
BindingDB Entry DOI: 10.7270/Q2VM4CK8 |
More data for this
Ligand-Target Pair | |
Prothrombin
(Homo sapiens (Human)) | BDBM50122190
(CHEMBL296737 | N-(5-chloro-2-ethylcarbamoylmethoxy...)Show SMILES CCNC(=O)COc1ccc(Cl)cc1CNC(=O)Cn1c(C)ccc(NS(=O)(=O)Cc2ccccc2)c1=O Show InChI InChI=1S/C26H29ClN4O6S/c1-3-28-25(33)16-37-23-12-10-21(27)13-20(23)14-29-24(32)15-31-18(2)9-11-22(26(31)34)30-38(35,36)17-19-7-5-4-6-8-19/h4-13,30H,3,14-17H2,1-2H3,(H,28,33)(H,29,32) | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| 0.0400 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Inhibition of thrombin in human plasma |
Bioorg Med Chem Lett 13: 161-4 (2002)
BindingDB Entry DOI: 10.7270/Q2348JQ0 |
More data for this
Ligand-Target Pair | |
Alpha-1A adrenergic receptor
(Rattus norvegicus (Rat)) | BDBM50100210
(6-Methoxy-3-[2-(6-methoxy-1,3,3a,4,5,9b-hexahydro-...)Show SMILES COc1cc2[nH]c(=O)n(CCN3C[C@@H]4CCc5c(OC)cccc5[C@@H]4C3)c(=O)c2s1 Show InChI InChI=1S/C22H25N3O4S/c1-28-18-5-3-4-14-15(18)7-6-13-11-24(12-16(13)14)8-9-25-21(26)20-17(23-22(25)27)10-19(29-2)30-20/h3-5,10,13,16H,6-9,11-12H2,1-2H3,(H,23,27)/t13-,16+/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| 0.0400 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary gland |
J Med Chem 44: 1971-85 (2001)
BindingDB Entry DOI: 10.7270/Q2KP81GH |
More data for this
Ligand-Target Pair | |
Alpha-1A adrenergic receptor
(Rattus norvegicus (Rat)) | BDBM50100221
(7,8-Dimethoxy-3-[2-(6-methoxy-1,3,3a,4,5,9b-hexahy...)Show SMILES COc1cccc2[C@@H]3CN(CCn4c(=O)[nH]c5c(OC)c(OC)ccc5c4=O)C[C@@H]3CCc12 Show InChI InChI=1S/C25H29N3O5/c1-31-20-6-4-5-16-17(20)8-7-15-13-27(14-19(15)16)11-12-28-24(29)18-9-10-21(32-2)23(33-3)22(18)26-25(28)30/h4-6,9-10,15,19H,7-8,11-14H2,1-3H3,(H,26,30)/t15-,19+/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| PubMed
| 0.0400 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description
Binding affinity to alpha-1A adrenergic receptor in rat submaxillary gland |
J Med Chem 44: 1971-85 (2001)
BindingDB Entry DOI: 10.7270/Q2KP81GH |
More data for this
Ligand-Target Pair | |
Neuronal acetylcholine receptor subunit alpha-4
(Rattus norvegicus (Rat)) | BDBM50279405
(CHEMBL488772 | cis-3-(5-Propyloxy-3-pyridinyl)-3,7...)Show InChI InChI=1S/C14H21N3O/c1-2-3-18-14-4-13(7-16-8-14)17-9-11-5-15-6-12(11)10-17/h4,7-8,11-12,15H,2-3,5-6,9-10H2,1H3/t11-,12+ | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0410 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [3H]cytisine from alpha4beta2 nicotinic acetylcholine receptor in rat brain minus cerebellum membrane |
J Med Chem 52: 4126-41 (2009)
Article DOI: 10.1021/jm900249k
BindingDB Entry DOI: 10.7270/Q2GT5P3R |
More data for this
Ligand-Target Pair | |
Dimer of Gag-Pol polyprotein [489-587]
(Human immunodeficiency virus type 1) | BDBM7031
((4R,5S,6S,7R)-4,7-bis(2H-1,3-benzodioxol-5-ylmethy...)Show SMILES CC(=O)c1cccc(CN2[C@H](Cc3ccc4OCOc4c3)[C@H](O)[C@@H](O)[C@@H](Cc3ccc4OCOc4c3)N(Cc3cccc(c3)C(C)=O)C2=O)c1 Show InChI InChI=1S/C39H38N2O9/c1-23(42)29-7-3-5-27(13-29)19-40-31(15-25-9-11-33-35(17-25)49-21-47-33)37(44)38(45)32(16-26-10-12-34-36(18-26)50-22-48-34)41(39(40)46)20-28-6-4-8-30(14-28)24(2)43/h3-14,17-18,31-32,37-38,44-45H,15-16,19-22H2,1-2H3/t31-,32-,37+,38+/m1/s1 | PDB
UniProtKB/SwissProt
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0430 | -61.6 | n/a | n/a | n/a | n/a | n/a | 5.5 | 37 |
DuPont Merck Pharmaceutical Company
| Assay Description
Inhibition of HIV protease was measured by assay of the cleavage of a fluorescent peptide substrate. The fluorescent product (2-aminobenzoyl-Ala-Thr-... |
J Med Chem 39: 2156-69 (1996)
Article DOI: 10.1021/jm960083n
BindingDB Entry DOI: 10.7270/Q257197T |
More data for this
Ligand-Target Pair | |
Neuronal acetylcholine receptor subunit alpha-4
(Rattus norvegicus (Rat)) | BDBM50049757
(()-2-(6-Chloro-pyridin-3-yl)-7-aza-bicyclo[2.2.1]h...)Show InChI InChI=1S/C11H13ClN2/c12-11-4-1-7(6-13-11)9-5-8-2-3-10(9)14-8/h1,4,6,8-10,14H,2-3,5H2 | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| Purchase
CHEMBL
PC cid
PC sid
PDB
UniChem
Patents
Similars
| Article
PubMed
| 0.0470 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [3H]cytisine from alpha4beta2 nicotinic acetylcholine receptor in rat brain minus cerebellum membrane |
J Med Chem 52: 4126-41 (2009)
Article DOI: 10.1021/jm900249k
BindingDB Entry DOI: 10.7270/Q2GT5P3R |
More data for this
Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM179904
(US10231963, Table C.8 | US10287250, Compound D.8 |...)Show SMILES C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2C[C@H]1CCCO1)C(N)=O |r,TLB:15:14:1:9.4.3| Show InChI InChI=1S/C20H28N2O2/c1-13-18-11-14-5-6-15(19(21)23)10-17(14)20(13,2)7-8-22(18)12-16-4-3-9-24-16/h5-6,10,13,16,18H,3-4,7-9,11-12H2,1-2H3,(H2,21,23)/t13-,16+,18+,20-/m0/s1 | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| US Patent
| 0.0500 | -58.8 | 58 | n/a | n/a | n/a | n/a | 7.5 | 25 |
ALKERMES PHARMA IRELAND LIMITED
US Patent
| Assay Description
The Ki (binding affinity) for u opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal o... |
US Patent US9133125 (2015)
BindingDB Entry DOI: 10.7270/Q2736PPB |
More data for this
Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM179904
(US10231963, Table C.8 | US10287250, Compound D.8 |...)Show SMILES C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2C[C@H]1CCCO1)C(N)=O |r,TLB:15:14:1:9.4.3| Show InChI InChI=1S/C20H28N2O2/c1-13-18-11-14-5-6-15(19(21)23)10-17(14)20(13,2)7-8-22(18)12-16-4-3-9-24-16/h5-6,10,13,16,18H,3-4,7-9,11-12H2,1-2H3,(H2,21,23)/t13-,16+,18+,20-/m0/s1 | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| US Patent
| 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
The Ki (binding affinity) for μ opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Jour... |
Citation and Details
BindingDB Entry DOI: 10.7270/Q2CJ8JBP |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 5
(Homo sapiens (Human)) | BDBM82460
(L-Ser-L-Ala-L-Asn-L-Ser-L-Asn-L-Pro-L-Ala-L-Met-L-...)Show SMILES CSCCC(NC(=O)C(C)NC(=O)C1CCCN1C(=O)C(CC(N)=O)NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(C)NC(=O)C(N)CO)C(=O)NC(C)C(=O)N1CCC[C@H]1C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(O)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)C(CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)C(CC(N)=O)NC(=O)C(CCCCN)NC1=O)[C@H](C)O)[C@H](C)O)C(O)=O |wU:211.220,130.221,wD:145.218,134.136,158.161,214.223,124.126,120.224,115.116,62.64,(6.16,1.45,;5.85,2.8,;5.24,3.82,;3.39,5.05,;1.54,6.16,;.92,4.93,;1.54,3.7,;3.39,2.59,;.92,2.46,;2.46,1.36,;.62,1.23,;3.39,,;5.85,60.59,;3.39,60.59,;5.5,59.26,;6.67,58.25,;5.85,58.03,;4.44,59.14,;5.03,57.91,;6.35,56.8,;4.87,56.68,;5.85,55.57,;6.56,54.33,;5.98,53.32,;6.71,53.19,;5.03,55.44,;5.5,54.21,;5.24,53.1,;4.5,52.98,;6.16,51.87,;6.75,50.64,;5.54,51.75,;6.08,50.51,;6.56,49.41,;5.5,49.28,;6.16,48.17,;6.67,46.94,;5.98,45.93,;6.71,45.8,;5.54,48.05,;5.85,46.82,;5.24,45.71,;4.5,45.59,;6.08,44.48,;5.4,44.35,;6.56,43.12,;6.56,42.01,;5.5,41.89,;5.03,40.66,;5.85,40.78,;6.35,39.43,;3.39,7.39,;5.24,6.28,;.92,8.62,;.62,9.86,;3.39,8.75,;.62,11.09,;2.46,9.98,;.62,12.32,;2.46,11.21,;4.31,11.43,;2.46,12.44,;.92,13.55,;1.54,14.78,;3.39,13.68,;.43,16.02,;.43,17.25,;1.91,16.14,;5.24,14.91,;5.85,13.89,;6.16,12.54,;6.16,11.3,;4.31,10.2,;6.16,10.07,;.92,18.48,;1.91,17.37,;.62,19.71,;.92,20.95,;2.46,19.84,;3.39,18.6,;3.39,17.59,;6.35,16.02,;4.87,16.23,;.92,22.18,;3.39,21.07,;.62,23.41,;.92,24.64,;2.46,23.53,;3.39,22.3,;5.85,21.28,;6.16,19.93,;5.85,18.82,;4.87,17.46,;6.35,17.25,;1.54,25.87,;3.39,24.76,;.92,27.11,;1.54,28.34,;3.39,27.23,;5.24,26,;5.85,24.98,;6.16,23.63,;5.85,22.52,;3.39,29.57,;5.24,28.46,;.92,30.8,;.92,32.03,;3.39,30.92,;1.54,33.27,;3.39,32.16,;1.54,34.5,;.92,35.73,;3.39,37.3,;3.39,35.85,;1.28,38.32,;.43,39.43,;.1,40.66,;.22,41.89,;2.33,43.46,;.7,44.48,;.06,45.59,;.1,46.82,;,48.05,;.92,46.94,;.22,49.28,;.62,48.17,;1.75,47.16,;.03,50.51,;,51.75,;.7,50.64,;.06,52.98,;.22,54.21,;.1,55.44,;1.28,54.33,;.43,56.68,;.92,55.57,;2.33,54.55,;.8,53.1,;1.85,51.96,;3.39,50.64,;2.46,51.75,;1.54,53.32,;.1,57.91,;.22,59.14,;.92,58.03,;.92,60.59,;1.28,59.26,;1.75,58.25,;3.39,57.01,;1.91,56.8,;3.39,55.44,;4.44,54.21,;3.76,53.1,;4.93,51.75,;5.4,50.51,;2.57,55.66,;3.39,54.43,;3.02,52.98,;2.28,53.19,;3.08,51.87,;4.06,50.85,;1.28,49.41,;1.85,48.27,;3.08,48.17,;3.39,46.82,;.8,45.71,;2.57,47.03,;2.46,48.05,;2.33,49.62,;3.7,52.09,;4.73,50.73,;4.44,49.28,;3.39,49.5,;4.31,48.27,;5.03,47.16,;3.02,45.59,;4.06,44.69,;5.5,43.25,;4.73,44.57,;3.76,45.71,;3.7,48.39,;4.21,46.94,;2.28,45.8,;1.54,45.93,;2.72,44.35,;4.44,43.12,;3.39,42.11,;3.39,40.66,;4.87,39.64,;4.21,40.78,;4.44,41.89,;2.04,44.57,;3.39,43.34,;2.33,42.23,;1.28,42.01,;1.75,41,;3.39,39.77,;5.5,38.32,;6.56,38.53,;.92,40.78,;1.91,39.55,;4.44,38.19,;3.39,38.41,;4.87,37.18,;5.85,36.07,;5.24,34.62,;5.24,33.39,;5.85,32.37,;.43,36.96,;.22,38.19,;1.91,37.09,;2.33,59.48,;2.57,58.12,;3.39,57.91,;.62,51.87,;1.37,50.85,;2.04,50.73,;.03,44.35,;.22,43.12,;1.28,43.25,)| Show InChI InChI=1S/C137H207N41O39S3/c1-69(154-113(194)82(37-19-22-47-138)159-115(196)85(40-25-50-149-136(145)146)160-118(199)87(44-45-106(188)189)163-116(197)86(41-26-51-150-137(147)148)164-130(211)101-43-27-52-177(101)133(214)72(4)156-114(195)88(46-54-218-7)158-110(191)71(3)155-129(210)100-42-28-53-178(100)134(215)95(61-104(144)186)171-126(207)96(65-180)172-124(205)93(59-102(142)184)165-111(192)70(2)153-112(193)80(141)64-179)109(190)152-63-105(187)157-98-67-219-220-68-99(135(216)217)174-127(208)97(66-181)173-132(213)108(74(6)183)176-125(206)91(57-77-33-15-10-16-34-77)170-131(212)107(73(5)182)175-119(200)84(39-21-24-49-140)161-122(203)92(58-78-62-151-81-36-18-17-35-79(78)81)168-121(202)90(56-76-31-13-9-14-32-76)166-120(201)89(55-75-29-11-8-12-30-75)167-123(204)94(60-103(143)185)169-117(198)83(162-128(98)209)38-20-23-48-139/h8-18,29-36,62,69-74,80,82-101,107-108,151,179-183H,19-28,37-61,63-68,138-141H2,1-7H3,(H2,142,184)(H2,143,185)(H2,144,186)(H,152,190)(H,153,193)(H,154,194)(H,155,210)(H,156,195)(H,157,187)(H,158,191)(H,159,196)(H,160,199)(H,161,203)(H,162,209)(H,163,197)(H,164,211)(H,165,192)(H,166,201)(H,167,204)(H,168,202)(H,169,198)(H,170,212)(H,171,207)(H,172,205)(H,173,213)(H,174,208)(H,175,200)(H,176,206)(H,188,189)(H,216,217)(H4,145,146,149)(H4,147,148,150)/t69?,70?,71?,72?,73-,74-,80?,82?,83?,84?,85?,86?,87?,88?,89?,90?,91+,92+,93?,94?,95?,96?,97+,98-,99+,100?,101-,107-,108+/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharma
Curated by PDSP Ki Database
| |
Eur J Pharmacol 348: 311-20 (1998)
Article DOI: 10.1016/s0014-2999(98)00159-9
BindingDB Entry DOI: 10.7270/Q2MK6BF9 |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 5
(Homo sapiens (Human)) | BDBM82460
(L-Ser-L-Ala-L-Asn-L-Ser-L-Asn-L-Pro-L-Ala-L-Met-L-...)Show SMILES CSCCC(NC(=O)C(C)NC(=O)C1CCCN1C(=O)C(CC(N)=O)NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(C)NC(=O)C(N)CO)C(=O)NC(C)C(=O)N1CCC[C@H]1C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(O)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)C(CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)C(CC(N)=O)NC(=O)C(CCCCN)NC1=O)[C@H](C)O)[C@H](C)O)C(O)=O |wU:211.220,130.221,wD:145.218,134.136,158.161,214.223,124.126,120.224,115.116,62.64,(6.16,1.45,;5.85,2.8,;5.24,3.82,;3.39,5.05,;1.54,6.16,;.92,4.93,;1.54,3.7,;3.39,2.59,;.92,2.46,;2.46,1.36,;.62,1.23,;3.39,,;5.85,60.59,;3.39,60.59,;5.5,59.26,;6.67,58.25,;5.85,58.03,;4.44,59.14,;5.03,57.91,;6.35,56.8,;4.87,56.68,;5.85,55.57,;6.56,54.33,;5.98,53.32,;6.71,53.19,;5.03,55.44,;5.5,54.21,;5.24,53.1,;4.5,52.98,;6.16,51.87,;6.75,50.64,;5.54,51.75,;6.08,50.51,;6.56,49.41,;5.5,49.28,;6.16,48.17,;6.67,46.94,;5.98,45.93,;6.71,45.8,;5.54,48.05,;5.85,46.82,;5.24,45.71,;4.5,45.59,;6.08,44.48,;5.4,44.35,;6.56,43.12,;6.56,42.01,;5.5,41.89,;5.03,40.66,;5.85,40.78,;6.35,39.43,;3.39,7.39,;5.24,6.28,;.92,8.62,;.62,9.86,;3.39,8.75,;.62,11.09,;2.46,9.98,;.62,12.32,;2.46,11.21,;4.31,11.43,;2.46,12.44,;.92,13.55,;1.54,14.78,;3.39,13.68,;.43,16.02,;.43,17.25,;1.91,16.14,;5.24,14.91,;5.85,13.89,;6.16,12.54,;6.16,11.3,;4.31,10.2,;6.16,10.07,;.92,18.48,;1.91,17.37,;.62,19.71,;.92,20.95,;2.46,19.84,;3.39,18.6,;3.39,17.59,;6.35,16.02,;4.87,16.23,;.92,22.18,;3.39,21.07,;.62,23.41,;.92,24.64,;2.46,23.53,;3.39,22.3,;5.85,21.28,;6.16,19.93,;5.85,18.82,;4.87,17.46,;6.35,17.25,;1.54,25.87,;3.39,24.76,;.92,27.11,;1.54,28.34,;3.39,27.23,;5.24,26,;5.85,24.98,;6.16,23.63,;5.85,22.52,;3.39,29.57,;5.24,28.46,;.92,30.8,;.92,32.03,;3.39,30.92,;1.54,33.27,;3.39,32.16,;1.54,34.5,;.92,35.73,;3.39,37.3,;3.39,35.85,;1.28,38.32,;.43,39.43,;.1,40.66,;.22,41.89,;2.33,43.46,;.7,44.48,;.06,45.59,;.1,46.82,;,48.05,;.92,46.94,;.22,49.28,;.62,48.17,;1.75,47.16,;.03,50.51,;,51.75,;.7,50.64,;.06,52.98,;.22,54.21,;.1,55.44,;1.28,54.33,;.43,56.68,;.92,55.57,;2.33,54.55,;.8,53.1,;1.85,51.96,;3.39,50.64,;2.46,51.75,;1.54,53.32,;.1,57.91,;.22,59.14,;.92,58.03,;.92,60.59,;1.28,59.26,;1.75,58.25,;3.39,57.01,;1.91,56.8,;3.39,55.44,;4.44,54.21,;3.76,53.1,;4.93,51.75,;5.4,50.51,;2.57,55.66,;3.39,54.43,;3.02,52.98,;2.28,53.19,;3.08,51.87,;4.06,50.85,;1.28,49.41,;1.85,48.27,;3.08,48.17,;3.39,46.82,;.8,45.71,;2.57,47.03,;2.46,48.05,;2.33,49.62,;3.7,52.09,;4.73,50.73,;4.44,49.28,;3.39,49.5,;4.31,48.27,;5.03,47.16,;3.02,45.59,;4.06,44.69,;5.5,43.25,;4.73,44.57,;3.76,45.71,;3.7,48.39,;4.21,46.94,;2.28,45.8,;1.54,45.93,;2.72,44.35,;4.44,43.12,;3.39,42.11,;3.39,40.66,;4.87,39.64,;4.21,40.78,;4.44,41.89,;2.04,44.57,;3.39,43.34,;2.33,42.23,;1.28,42.01,;1.75,41,;3.39,39.77,;5.5,38.32,;6.56,38.53,;.92,40.78,;1.91,39.55,;4.44,38.19,;3.39,38.41,;4.87,37.18,;5.85,36.07,;5.24,34.62,;5.24,33.39,;5.85,32.37,;.43,36.96,;.22,38.19,;1.91,37.09,;2.33,59.48,;2.57,58.12,;3.39,57.91,;.62,51.87,;1.37,50.85,;2.04,50.73,;.03,44.35,;.22,43.12,;1.28,43.25,)| Show InChI InChI=1S/C137H207N41O39S3/c1-69(154-113(194)82(37-19-22-47-138)159-115(196)85(40-25-50-149-136(145)146)160-118(199)87(44-45-106(188)189)163-116(197)86(41-26-51-150-137(147)148)164-130(211)101-43-27-52-177(101)133(214)72(4)156-114(195)88(46-54-218-7)158-110(191)71(3)155-129(210)100-42-28-53-178(100)134(215)95(61-104(144)186)171-126(207)96(65-180)172-124(205)93(59-102(142)184)165-111(192)70(2)153-112(193)80(141)64-179)109(190)152-63-105(187)157-98-67-219-220-68-99(135(216)217)174-127(208)97(66-181)173-132(213)108(74(6)183)176-125(206)91(57-77-33-15-10-16-34-77)170-131(212)107(73(5)182)175-119(200)84(39-21-24-49-140)161-122(203)92(58-78-62-151-81-36-18-17-35-79(78)81)168-121(202)90(56-76-31-13-9-14-32-76)166-120(201)89(55-75-29-11-8-12-30-75)167-123(204)94(60-103(143)185)169-117(198)83(162-128(98)209)38-20-23-48-139/h8-18,29-36,62,69-74,80,82-101,107-108,151,179-183H,19-28,37-61,63-68,138-141H2,1-7H3,(H2,142,184)(H2,143,185)(H2,144,186)(H,152,190)(H,153,193)(H,154,194)(H,155,210)(H,156,195)(H,157,187)(H,158,191)(H,159,196)(H,160,199)(H,161,203)(H,162,209)(H,163,197)(H,164,211)(H,165,192)(H,166,201)(H,167,204)(H,168,202)(H,169,198)(H,170,212)(H,171,207)(H,172,205)(H,173,213)(H,174,208)(H,175,200)(H,176,206)(H,188,189)(H,216,217)(H4,145,146,149)(H4,147,148,150)/t69?,70?,71?,72?,73-,74-,80?,82?,83?,84?,85?,86?,87?,88?,89?,90?,91+,92+,93?,94?,95?,96?,97+,98-,99+,100?,101-,107-,108+/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharma
Curated by PDSP Ki Database
| |
Eur J Pharmacol 348: 311-20 (1998)
Article DOI: 10.1016/s0014-2999(98)00159-9
BindingDB Entry DOI: 10.7270/Q2MK6BF9 |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 5
(Homo sapiens (Human)) | BDBM82460
(L-Ser-L-Ala-L-Asn-L-Ser-L-Asn-L-Pro-L-Ala-L-Met-L-...)Show SMILES CSCCC(NC(=O)C(C)NC(=O)C1CCCN1C(=O)C(CC(N)=O)NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(C)NC(=O)C(N)CO)C(=O)NC(C)C(=O)N1CCC[C@H]1C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(O)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)C(CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)C(CC(N)=O)NC(=O)C(CCCCN)NC1=O)[C@H](C)O)[C@H](C)O)C(O)=O |wU:211.220,130.221,wD:145.218,134.136,158.161,214.223,124.126,120.224,115.116,62.64,(6.16,1.45,;5.85,2.8,;5.24,3.82,;3.39,5.05,;1.54,6.16,;.92,4.93,;1.54,3.7,;3.39,2.59,;.92,2.46,;2.46,1.36,;.62,1.23,;3.39,,;5.85,60.59,;3.39,60.59,;5.5,59.26,;6.67,58.25,;5.85,58.03,;4.44,59.14,;5.03,57.91,;6.35,56.8,;4.87,56.68,;5.85,55.57,;6.56,54.33,;5.98,53.32,;6.71,53.19,;5.03,55.44,;5.5,54.21,;5.24,53.1,;4.5,52.98,;6.16,51.87,;6.75,50.64,;5.54,51.75,;6.08,50.51,;6.56,49.41,;5.5,49.28,;6.16,48.17,;6.67,46.94,;5.98,45.93,;6.71,45.8,;5.54,48.05,;5.85,46.82,;5.24,45.71,;4.5,45.59,;6.08,44.48,;5.4,44.35,;6.56,43.12,;6.56,42.01,;5.5,41.89,;5.03,40.66,;5.85,40.78,;6.35,39.43,;3.39,7.39,;5.24,6.28,;.92,8.62,;.62,9.86,;3.39,8.75,;.62,11.09,;2.46,9.98,;.62,12.32,;2.46,11.21,;4.31,11.43,;2.46,12.44,;.92,13.55,;1.54,14.78,;3.39,13.68,;.43,16.02,;.43,17.25,;1.91,16.14,;5.24,14.91,;5.85,13.89,;6.16,12.54,;6.16,11.3,;4.31,10.2,;6.16,10.07,;.92,18.48,;1.91,17.37,;.62,19.71,;.92,20.95,;2.46,19.84,;3.39,18.6,;3.39,17.59,;6.35,16.02,;4.87,16.23,;.92,22.18,;3.39,21.07,;.62,23.41,;.92,24.64,;2.46,23.53,;3.39,22.3,;5.85,21.28,;6.16,19.93,;5.85,18.82,;4.87,17.46,;6.35,17.25,;1.54,25.87,;3.39,24.76,;.92,27.11,;1.54,28.34,;3.39,27.23,;5.24,26,;5.85,24.98,;6.16,23.63,;5.85,22.52,;3.39,29.57,;5.24,28.46,;.92,30.8,;.92,32.03,;3.39,30.92,;1.54,33.27,;3.39,32.16,;1.54,34.5,;.92,35.73,;3.39,37.3,;3.39,35.85,;1.28,38.32,;.43,39.43,;.1,40.66,;.22,41.89,;2.33,43.46,;.7,44.48,;.06,45.59,;.1,46.82,;,48.05,;.92,46.94,;.22,49.28,;.62,48.17,;1.75,47.16,;.03,50.51,;,51.75,;.7,50.64,;.06,52.98,;.22,54.21,;.1,55.44,;1.28,54.33,;.43,56.68,;.92,55.57,;2.33,54.55,;.8,53.1,;1.85,51.96,;3.39,50.64,;2.46,51.75,;1.54,53.32,;.1,57.91,;.22,59.14,;.92,58.03,;.92,60.59,;1.28,59.26,;1.75,58.25,;3.39,57.01,;1.91,56.8,;3.39,55.44,;4.44,54.21,;3.76,53.1,;4.93,51.75,;5.4,50.51,;2.57,55.66,;3.39,54.43,;3.02,52.98,;2.28,53.19,;3.08,51.87,;4.06,50.85,;1.28,49.41,;1.85,48.27,;3.08,48.17,;3.39,46.82,;.8,45.71,;2.57,47.03,;2.46,48.05,;2.33,49.62,;3.7,52.09,;4.73,50.73,;4.44,49.28,;3.39,49.5,;4.31,48.27,;5.03,47.16,;3.02,45.59,;4.06,44.69,;5.5,43.25,;4.73,44.57,;3.76,45.71,;3.7,48.39,;4.21,46.94,;2.28,45.8,;1.54,45.93,;2.72,44.35,;4.44,43.12,;3.39,42.11,;3.39,40.66,;4.87,39.64,;4.21,40.78,;4.44,41.89,;2.04,44.57,;3.39,43.34,;2.33,42.23,;1.28,42.01,;1.75,41,;3.39,39.77,;5.5,38.32,;6.56,38.53,;.92,40.78,;1.91,39.55,;4.44,38.19,;3.39,38.41,;4.87,37.18,;5.85,36.07,;5.24,34.62,;5.24,33.39,;5.85,32.37,;.43,36.96,;.22,38.19,;1.91,37.09,;2.33,59.48,;2.57,58.12,;3.39,57.91,;.62,51.87,;1.37,50.85,;2.04,50.73,;.03,44.35,;.22,43.12,;1.28,43.25,)| Show InChI InChI=1S/C137H207N41O39S3/c1-69(154-113(194)82(37-19-22-47-138)159-115(196)85(40-25-50-149-136(145)146)160-118(199)87(44-45-106(188)189)163-116(197)86(41-26-51-150-137(147)148)164-130(211)101-43-27-52-177(101)133(214)72(4)156-114(195)88(46-54-218-7)158-110(191)71(3)155-129(210)100-42-28-53-178(100)134(215)95(61-104(144)186)171-126(207)96(65-180)172-124(205)93(59-102(142)184)165-111(192)70(2)153-112(193)80(141)64-179)109(190)152-63-105(187)157-98-67-219-220-68-99(135(216)217)174-127(208)97(66-181)173-132(213)108(74(6)183)176-125(206)91(57-77-33-15-10-16-34-77)170-131(212)107(73(5)182)175-119(200)84(39-21-24-49-140)161-122(203)92(58-78-62-151-81-36-18-17-35-79(78)81)168-121(202)90(56-76-31-13-9-14-32-76)166-120(201)89(55-75-29-11-8-12-30-75)167-123(204)94(60-103(143)185)169-117(198)83(162-128(98)209)38-20-23-48-139/h8-18,29-36,62,69-74,80,82-101,107-108,151,179-183H,19-28,37-61,63-68,138-141H2,1-7H3,(H2,142,184)(H2,143,185)(H2,144,186)(H,152,190)(H,153,193)(H,154,194)(H,155,210)(H,156,195)(H,157,187)(H,158,191)(H,159,196)(H,160,199)(H,161,203)(H,162,209)(H,163,197)(H,164,211)(H,165,192)(H,166,201)(H,167,204)(H,168,202)(H,169,198)(H,170,212)(H,171,207)(H,172,205)(H,173,213)(H,174,208)(H,175,200)(H,176,206)(H,188,189)(H,216,217)(H4,145,146,149)(H4,147,148,150)/t69?,70?,71?,72?,73-,74-,80?,82?,83?,84?,85?,86?,87?,88?,89?,90?,91+,92+,93?,94?,95?,96?,97+,98-,99+,100?,101-,107-,108+/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharma AG
Curated by PDSP Ki Database
| |
Naunyn Schmiedebergs Arch Pharmacol 360: 488-99 (1999)
Article DOI: 10.1007/s002109900141
BindingDB Entry DOI: 10.7270/Q2Q23XTW |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 2
(Homo sapiens (Human)) | BDBM82464
(CAS_71306 | NSC_71306 | RC 160 | Vapreotide)Show SMILES CC(C)C1NC(=O)C(CCCCN)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(CSSCC(NC1=O)C(=O)NC(Cc1c[nH]c2ccccc12)C(N)=O)NC(=O)C(N)Cc1ccccc1 Show InChI InChI=1S/C57H70N12O9S2/c1-32(2)49-57(78)68-48(55(76)64-44(50(60)71)26-35-28-61-41-16-8-6-14-38(35)41)31-80-79-30-47(67-51(72)40(59)24-33-12-4-3-5-13-33)56(77)65-45(25-34-19-21-37(70)22-20-34)53(74)66-46(27-36-29-62-42-17-9-7-15-39(36)42)54(75)63-43(52(73)69-49)18-10-11-23-58/h3-9,12-17,19-22,28-29,32,40,43-49,61-62,70H,10-11,18,23-27,30-31,58-59H2,1-2H3,(H2,60,71)(H,63,75)(H,64,76)(H,65,77)(H,66,74)(H,67,72)(H,68,78)(H,69,73) | PDB
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharma
Curated by PDSP Ki Database
| |
Eur J Pharmacol 348: 311-20 (1998)
Article DOI: 10.1016/s0014-2999(98)00159-9
BindingDB Entry DOI: 10.7270/Q2MK6BF9 |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 2
(Homo sapiens (Human)) | BDBM82460
(L-Ser-L-Ala-L-Asn-L-Ser-L-Asn-L-Pro-L-Ala-L-Met-L-...)Show SMILES CSCCC(NC(=O)C(C)NC(=O)C1CCCN1C(=O)C(CC(N)=O)NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(C)NC(=O)C(N)CO)C(=O)NC(C)C(=O)N1CCC[C@H]1C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(O)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)C(CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)C(CC(N)=O)NC(=O)C(CCCCN)NC1=O)[C@H](C)O)[C@H](C)O)C(O)=O |wU:211.220,130.221,wD:145.218,134.136,158.161,214.223,124.126,120.224,115.116,62.64,(6.16,1.45,;5.85,2.8,;5.24,3.82,;3.39,5.05,;1.54,6.16,;.92,4.93,;1.54,3.7,;3.39,2.59,;.92,2.46,;2.46,1.36,;.62,1.23,;3.39,,;5.85,60.59,;3.39,60.59,;5.5,59.26,;6.67,58.25,;5.85,58.03,;4.44,59.14,;5.03,57.91,;6.35,56.8,;4.87,56.68,;5.85,55.57,;6.56,54.33,;5.98,53.32,;6.71,53.19,;5.03,55.44,;5.5,54.21,;5.24,53.1,;4.5,52.98,;6.16,51.87,;6.75,50.64,;5.54,51.75,;6.08,50.51,;6.56,49.41,;5.5,49.28,;6.16,48.17,;6.67,46.94,;5.98,45.93,;6.71,45.8,;5.54,48.05,;5.85,46.82,;5.24,45.71,;4.5,45.59,;6.08,44.48,;5.4,44.35,;6.56,43.12,;6.56,42.01,;5.5,41.89,;5.03,40.66,;5.85,40.78,;6.35,39.43,;3.39,7.39,;5.24,6.28,;.92,8.62,;.62,9.86,;3.39,8.75,;.62,11.09,;2.46,9.98,;.62,12.32,;2.46,11.21,;4.31,11.43,;2.46,12.44,;.92,13.55,;1.54,14.78,;3.39,13.68,;.43,16.02,;.43,17.25,;1.91,16.14,;5.24,14.91,;5.85,13.89,;6.16,12.54,;6.16,11.3,;4.31,10.2,;6.16,10.07,;.92,18.48,;1.91,17.37,;.62,19.71,;.92,20.95,;2.46,19.84,;3.39,18.6,;3.39,17.59,;6.35,16.02,;4.87,16.23,;.92,22.18,;3.39,21.07,;.62,23.41,;.92,24.64,;2.46,23.53,;3.39,22.3,;5.85,21.28,;6.16,19.93,;5.85,18.82,;4.87,17.46,;6.35,17.25,;1.54,25.87,;3.39,24.76,;.92,27.11,;1.54,28.34,;3.39,27.23,;5.24,26,;5.85,24.98,;6.16,23.63,;5.85,22.52,;3.39,29.57,;5.24,28.46,;.92,30.8,;.92,32.03,;3.39,30.92,;1.54,33.27,;3.39,32.16,;1.54,34.5,;.92,35.73,;3.39,37.3,;3.39,35.85,;1.28,38.32,;.43,39.43,;.1,40.66,;.22,41.89,;2.33,43.46,;.7,44.48,;.06,45.59,;.1,46.82,;,48.05,;.92,46.94,;.22,49.28,;.62,48.17,;1.75,47.16,;.03,50.51,;,51.75,;.7,50.64,;.06,52.98,;.22,54.21,;.1,55.44,;1.28,54.33,;.43,56.68,;.92,55.57,;2.33,54.55,;.8,53.1,;1.85,51.96,;3.39,50.64,;2.46,51.75,;1.54,53.32,;.1,57.91,;.22,59.14,;.92,58.03,;.92,60.59,;1.28,59.26,;1.75,58.25,;3.39,57.01,;1.91,56.8,;3.39,55.44,;4.44,54.21,;3.76,53.1,;4.93,51.75,;5.4,50.51,;2.57,55.66,;3.39,54.43,;3.02,52.98,;2.28,53.19,;3.08,51.87,;4.06,50.85,;1.28,49.41,;1.85,48.27,;3.08,48.17,;3.39,46.82,;.8,45.71,;2.57,47.03,;2.46,48.05,;2.33,49.62,;3.7,52.09,;4.73,50.73,;4.44,49.28,;3.39,49.5,;4.31,48.27,;5.03,47.16,;3.02,45.59,;4.06,44.69,;5.5,43.25,;4.73,44.57,;3.76,45.71,;3.7,48.39,;4.21,46.94,;2.28,45.8,;1.54,45.93,;2.72,44.35,;4.44,43.12,;3.39,42.11,;3.39,40.66,;4.87,39.64,;4.21,40.78,;4.44,41.89,;2.04,44.57,;3.39,43.34,;2.33,42.23,;1.28,42.01,;1.75,41,;3.39,39.77,;5.5,38.32,;6.56,38.53,;.92,40.78,;1.91,39.55,;4.44,38.19,;3.39,38.41,;4.87,37.18,;5.85,36.07,;5.24,34.62,;5.24,33.39,;5.85,32.37,;.43,36.96,;.22,38.19,;1.91,37.09,;2.33,59.48,;2.57,58.12,;3.39,57.91,;.62,51.87,;1.37,50.85,;2.04,50.73,;.03,44.35,;.22,43.12,;1.28,43.25,)| Show InChI InChI=1S/C137H207N41O39S3/c1-69(154-113(194)82(37-19-22-47-138)159-115(196)85(40-25-50-149-136(145)146)160-118(199)87(44-45-106(188)189)163-116(197)86(41-26-51-150-137(147)148)164-130(211)101-43-27-52-177(101)133(214)72(4)156-114(195)88(46-54-218-7)158-110(191)71(3)155-129(210)100-42-28-53-178(100)134(215)95(61-104(144)186)171-126(207)96(65-180)172-124(205)93(59-102(142)184)165-111(192)70(2)153-112(193)80(141)64-179)109(190)152-63-105(187)157-98-67-219-220-68-99(135(216)217)174-127(208)97(66-181)173-132(213)108(74(6)183)176-125(206)91(57-77-33-15-10-16-34-77)170-131(212)107(73(5)182)175-119(200)84(39-21-24-49-140)161-122(203)92(58-78-62-151-81-36-18-17-35-79(78)81)168-121(202)90(56-76-31-13-9-14-32-76)166-120(201)89(55-75-29-11-8-12-30-75)167-123(204)94(60-103(143)185)169-117(198)83(162-128(98)209)38-20-23-48-139/h8-18,29-36,62,69-74,80,82-101,107-108,151,179-183H,19-28,37-61,63-68,138-141H2,1-7H3,(H2,142,184)(H2,143,185)(H2,144,186)(H,152,190)(H,153,193)(H,154,194)(H,155,210)(H,156,195)(H,157,187)(H,158,191)(H,159,196)(H,160,199)(H,161,203)(H,162,209)(H,163,197)(H,164,211)(H,165,192)(H,166,201)(H,167,204)(H,168,202)(H,169,198)(H,170,212)(H,171,207)(H,172,205)(H,173,213)(H,174,208)(H,175,200)(H,176,206)(H,188,189)(H,216,217)(H4,145,146,149)(H4,147,148,150)/t69?,70?,71?,72?,73-,74-,80?,82?,83?,84?,85?,86?,87?,88?,89?,90?,91+,92+,93?,94?,95?,96?,97+,98-,99+,100?,101-,107-,108+/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharma
Curated by PDSP Ki Database
| |
Eur J Pharmacol 348: 311-20 (1998)
Article DOI: 10.1016/s0014-2999(98)00159-9
BindingDB Entry DOI: 10.7270/Q2MK6BF9 |
More data for this
Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM179904
(US10231963, Table C.8 | US10287250, Compound D.8 |...)Show SMILES C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2C[C@H]1CCCO1)C(N)=O |r,TLB:15:14:1:9.4.3| Show InChI InChI=1S/C20H28N2O2/c1-13-18-11-14-5-6-15(19(21)23)10-17(14)20(13,2)7-8-22(18)12-16-4-3-9-24-16/h5-6,10,13,16,18H,3-4,7-9,11-12H2,1-2H3,(H2,21,23)/t13-,16+,18+,20-/m0/s1 | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| US Patent
| 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ALKERMES PHARMA IRELAND LIMITED
US Patent
| Assay Description
The Ki (binding affinity) for μ opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Jour... |
US Patent US10752592 (2020)
BindingDB Entry DOI: 10.7270/Q23R0WX0 |
More data for this
Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM179904
(US10231963, Table C.8 | US10287250, Compound D.8 |...)Show SMILES C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2C[C@H]1CCCO1)C(N)=O |r,TLB:15:14:1:9.4.3| Show InChI InChI=1S/C20H28N2O2/c1-13-18-11-14-5-6-15(19(21)23)10-17(14)20(13,2)7-8-22(18)12-16-4-3-9-24-16/h5-6,10,13,16,18H,3-4,7-9,11-12H2,1-2H3,(H2,21,23)/t13-,16+,18+,20-/m0/s1 | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| US Patent
| 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ALKERMES PHARMA IRELAND LIMITED
US Patent
| Assay Description
The Ki (binding affinity) for μ opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Jour... |
US Patent US10736890 (2020)
BindingDB Entry DOI: 10.7270/Q2F47S5F |
More data for this
Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM179904
(US10231963, Table C.8 | US10287250, Compound D.8 |...)Show SMILES C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2C[C@H]1CCCO1)C(N)=O |r,TLB:15:14:1:9.4.3| Show InChI InChI=1S/C20H28N2O2/c1-13-18-11-14-5-6-15(19(21)23)10-17(14)20(13,2)7-8-22(18)12-16-4-3-9-24-16/h5-6,10,13,16,18H,3-4,7-9,11-12H2,1-2H3,(H2,21,23)/t13-,16+,18+,20-/m0/s1 | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| US Patent
| 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Bristol-Myers Squibb Company
| Assay Description
The Ki (binding affinity) for μ opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Jour... |
Bioorg Med Chem Lett 17: 4284-9 (2007)
BindingDB Entry DOI: 10.7270/Q2125W08 |
More data for this
Ligand-Target Pair | |
Calcitonin gene-related peptide type 1 receptor
(Homo sapiens (Human)) | BDBM50342636
(CHEMBL1770726 | N-((6S,9R)-6-(2,3-difluorophenyl)-...)Show SMILES CCOC(C)(C)c1cnc2[C@@H](CC[C@H](Cn12)c1cccc(F)c1F)NC(=O)N1CCC2(CC1)OC(=O)Nc1ncccc21 |r| Show InChI InChI=1S/C31H36F2N6O4/c1-4-42-30(2,3)24-17-35-27-23(11-10-19(18-39(24)27)20-7-5-9-22(32)25(20)33)36-28(40)38-15-12-31(13-16-38)21-8-6-14-34-26(21)37-29(41)43-31/h5-9,14,17,19,23H,4,10-13,15-16,18H2,1-3H3,(H,36,40)(H,34,37,41)/t19-,23-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [125I]-CGRP from human recombinant CGRP receptor |
Bioorg Med Chem Lett 21: 2683-6 (2011)
Article DOI: 10.1016/j.bmcl.2010.12.054
BindingDB Entry DOI: 10.7270/Q2VM4CK8 |
More data for this
Ligand-Target Pair | |
Calcitonin gene-related peptide type 1 receptor
(Homo sapiens (Human)) | BDBM50342634
(CHEMBL1770724 | N-((6S,9R)-6-(2,3-difluorophenyl)-...)Show SMILES COC(C)(C)c1cnc2[C@@H](CC[C@H](Cn12)c1cccc(F)c1F)NC(=O)N1CCC2(CC1)OC(=O)Nc1ncccc21 |r| Show InChI InChI=1S/C30H34F2N6O4/c1-29(2,41-3)23-16-34-26-22(10-9-18(17-38(23)26)19-6-4-8-21(31)24(19)32)35-27(39)37-14-11-30(12-15-37)20-7-5-13-33-25(20)36-28(40)42-30/h4-8,13,16,18,22H,9-12,14-15,17H2,1-3H3,(H,35,39)(H,33,36,40)/t18-,22-/m1/s1 | PDB
UniProtKB/SwissProt
antibodypedia
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Patents
Similars
| Article
PubMed
| 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Merck Research Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [125I]-CGRP from human recombinant CGRP receptor |
Bioorg Med Chem Lett 21: 2683-6 (2011)
Article DOI: 10.1016/j.bmcl.2010.12.054
BindingDB Entry DOI: 10.7270/Q2VM4CK8 |
More data for this
Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM179904
(US10231963, Table C.8 | US10287250, Compound D.8 |...)Show SMILES C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2C[C@H]1CCCO1)C(N)=O |r,TLB:15:14:1:9.4.3| Show InChI InChI=1S/C20H28N2O2/c1-13-18-11-14-5-6-15(19(21)23)10-17(14)20(13,2)7-8-22(18)12-16-4-3-9-24-16/h5-6,10,13,16,18H,3-4,7-9,11-12H2,1-2H3,(H2,21,23)/t13-,16+,18+,20-/m0/s1 | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| US Patent
| 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
ALKERMES PHARMA IRELAND LIMITED
US Patent
| Assay Description
The Ki (binding affinity) for opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of ... |
US Patent US9656961 (2017)
BindingDB Entry DOI: 10.7270/Q2PR7Z13 |
More data for this
Ligand-Target Pair | |
Mu-type opioid receptor
(Homo sapiens (Human)) | BDBM179904
(US10231963, Table C.8 | US10287250, Compound D.8 |...)Show SMILES C[C@H]1[C@H]2Cc3ccc(cc3[C@@]1(C)CCN2C[C@H]1CCCO1)C(N)=O |r,TLB:15:14:1:9.4.3| Show InChI InChI=1S/C20H28N2O2/c1-13-18-11-14-5-6-15(19(21)23)10-17(14)20(13,2)7-8-22(18)12-16-4-3-9-24-16/h5-6,10,13,16,18H,3-4,7-9,11-12H2,1-2H3,(H2,21,23)/t13-,16+,18+,20-/m0/s1 | PDB
NCI pathway
Reactome pathway
KEGG
UniProtKB/SwissProt
B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| US Patent
| 0.0500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Universita degli Studi di Bari
| Assay Description
The Ki (binding affinity) for opioid receptors was determined using a competitive displacement assay as previously described in Neumeyer (Journal of ... |
J Med Chem 50: 4214-21 (2007)
BindingDB Entry DOI: 10.7270/Q2W66P26 |
More data for this
Ligand-Target Pair | |
Neuronal acetylcholine receptor subunit alpha-4
(Rattus norvegicus (Rat)) | BDBM50278878
(CHEMBL502567 | cis-3-(5-Isopropyloxy-3-pyridinyl)-...)Show InChI InChI=1S/C14H21N3O/c1-10(2)18-14-3-13(6-16-7-14)17-8-11-4-15-5-12(11)9-17/h3,6-7,10-12,15H,4-5,8-9H2,1-2H3/t11-,12+ | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0510 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [3H]cytisine from alpha4beta2 nicotinic acetylcholine receptor in rat brain minus cerebellum membrane |
J Med Chem 52: 4126-41 (2009)
Article DOI: 10.1021/jm900249k
BindingDB Entry DOI: 10.7270/Q2GT5P3R |
More data for this
Ligand-Target Pair | |
Alpha-1D adrenergic receptor
(Homo sapiens (Human)) | BDBM50060964
((R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-...)Show SMILES CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(c1)S(N)(=O)=O Show InChI InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
DrugBank
MCE
KEGG
PC cid
PC sid
PDB
UniChem
Patents
Similars
| DrugBank
Article
PubMed
| 0.0560 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by PDSP Ki Database
| |
J Pharmacol Exp Ther 300: 478-86 (2002)
Article DOI: 10.1124/jpet.300.2.478
BindingDB Entry DOI: 10.7270/Q2HX1B77 |
More data for this
Ligand-Target Pair | |
Neuronal acetylcholine receptor subunit alpha-4
(Rattus norvegicus (Rat)) | BDBM50278877
(CHEMBL524911 | cis-2-(5-(Benzyloxy)pyridin-3-yl)oc...)Show SMILES C(Oc1cncc(c1)N1C[C@@H]2CNC[C@@H]2C1)c1ccccc1 |r| Show InChI InChI=1S/C18H21N3O/c1-2-4-14(5-3-1)13-22-18-6-17(9-20-10-18)21-11-15-7-19-8-16(15)12-21/h1-6,9-10,15-16,19H,7-8,11-13H2/t15-,16+ | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0580 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [3H]cytisine from alpha4beta2 nicotinic acetylcholine receptor in rat brain minus cerebellum membrane |
J Med Chem 52: 4126-41 (2009)
Article DOI: 10.1021/jm900249k
BindingDB Entry DOI: 10.7270/Q2GT5P3R |
More data for this
Ligand-Target Pair | |
Alpha-1D adrenergic receptor
(Homo sapiens (Human)) | BDBM50060964
((R)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-...)Show SMILES CCOc1ccccc1OCCN[C@H](C)Cc1ccc(OC)c(c1)S(N)(=O)=O Show InChI InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
DrugBank
MCE
KEGG
PC cid
PC sid
PDB
UniChem
Patents
Similars
| DrugBank
Article
PubMed
| 0.0580 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description
Binding affinity against human adrenergic receptor subtype Alpha-1D adrenergic receptor using [3H]-prazosin as radioligand |
J Med Chem 40: 3141-3 (1997)
Article DOI: 10.1021/jm970364a
BindingDB Entry DOI: 10.7270/Q2R78DBB |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 5
(Homo sapiens (Human)) | BDBM85246
(CST17 | Cortistatin | Cortistatin-17 | L-Asp-L-Arg...)Show SMILES CSCC[C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@H]1CSSC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCN=C(N)N)NC1=O)[C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O |wU:67.141,135.143,56.57,71.73,50.51,44.45,94.98,105.110,141.147,116.122,124.130,8.15,19.19,wD:80.82,40.144,35.35,31.32,4.4,(40.86,-1.58,;39.4,-1.1,;38.25,-2.13,;36.79,-1.65,;35.64,-2.68,;35.97,-4.19,;37.43,-4.67,;38.57,-3.64,;37.75,-6.17,;36.61,-7.2,;36.93,-8.71,;35.78,-9.74,;36.1,-11.25,;34.96,-12.28,;35.28,-13.78,;33.49,-11.8,;39.21,-6.65,;39.53,-8.16,;38.39,-9.19,;41,-8.63,;42.14,-7.6,;41.32,-10.14,;42.78,-10.61,;43.1,-12.12,;43.93,-9.58,;34.18,-2.21,;33.04,-3.24,;33.86,-.7,;34.89,.44,;34.12,1.78,;32.61,1.46,;32.45,-.08,;31.12,-.85,;31.12,-2.39,;29.79,-.08,;28.45,-.85,;27.12,-.08,;27.12,1.46,;25.79,2.23,;25.79,3.77,;24.45,4.54,;23.12,3.77,;23.12,2.23,;24.45,1.46,;21.78,1.46,;20.45,2.23,;20.45,3.77,;21.78,-.08,;20.45,-.85,;20.45,-2.39,;19.12,-.08,;19.12,1.46,;17.78,2.23,;17.78,-.85,;17.78,-2.39,;19.12,-3.16,;16.45,-3.16,;15.12,-2.39,;15.12,-.85,;16.45,-.08,;16.45,1.46,;15.12,2.23,;13.78,1.46,;13.78,-.08,;16.45,-4.7,;15.12,-5.47,;13.78,-6.24,;13.78,-4.7,;12.45,-5.47,;11.11,-4.7,;11.11,-3.16,;9.78,-5.47,;8.33,-4.94,;6.89,-5.47,;5.71,-4.48,;4.26,-5,;3.08,-4.01,;9.78,-7.01,;11.11,-7.78,;11.11,-9.32,;12.45,-7.01,;11.92,-5.56,;10.4,-5.29,;9.3,-6.36,;7.95,-5.64,;8.21,-4.13,;7.26,-2.92,;7.83,-1.49,;9.36,-1.27,;10.31,-2.49,;9.74,-3.92,;13.78,-7.78,;15.12,-7.01,;16.45,-6.24,;16.45,-7.78,;16.45,-9.32,;15.12,-10.09,;13.78,-9.32,;12.45,-10.09,;12.45,-11.63,;13.78,-12.4,;15.12,-11.63,;17.78,-7.01,;19.12,-7.78,;19.12,-9.32,;20.45,-7.01,;21.78,-7.78,;21.78,-9.32,;20.45,-10.09,;20.45,-11.63,;21.78,-12.4,;23.12,-11.63,;23.12,-10.09,;20.45,-5.47,;21.78,-4.7,;21.78,-3.16,;23.12,-5.47,;23.12,-7.01,;24.45,-7.78,;24.45,-9.32,;25.97,-8.04,;24.45,-4.7,;25.79,-5.47,;26.77,-6.65,;27.12,-4.7,;28.45,-5.47,;28.45,-7.01,;29.79,-7.78,;29.79,-9.32,;31.12,-10.09,;31.12,-11.63,;32.45,-9.32,;27.12,-3.16,;28.45,-2.39,;29.79,-3.16,;13.78,-3.16,;13.78,-1.62,;12.45,-2.39,;24.45,6.08,;23.12,6.85,;25.79,6.85,;25.79,8.39,;24.45,9.16,;24.45,10.7,;23.12,11.47,;23.12,13.01,;21.78,13.78,;27.12,9.16,;27.12,10.7,;28.45,8.39,)| Show InChI InChI=1S/C96H139N27O24S3/c1-52(126)77-92(144)117-67(43-55-25-10-5-11-26-55)84(136)118-70(48-124)87(139)119-71(49-125)88(140)120-72(90(142)112-64(94(146)147)30-15-17-36-98)50-149-150-51-73(121-91(143)74-33-20-39-123(74)93(145)63(34-40-148-2)111-79(131)61(31-18-37-105-95(101)102)108-78(130)58(99)45-76(128)129)89(141)110-62(32-19-38-106-96(103)104)80(132)116-69(46-75(100)127)86(138)114-65(41-53-21-6-3-7-22-53)82(134)113-66(42-54-23-8-4-9-24-54)83(135)115-68(44-56-47-107-59-28-13-12-27-57(56)59)85(137)109-60(81(133)122-77)29-14-16-35-97/h3-13,21-28,47,52,58,60-74,77,107,124-126H,14-20,29-46,48-51,97-99H2,1-2H3,(H2,100,127)(H,108,130)(H,109,137)(H,110,141)(H,111,131)(H,112,142)(H,113,134)(H,114,138)(H,115,135)(H,116,132)(H,117,144)(H,118,136)(H,119,139)(H,120,140)(H,121,143)(H,122,133)(H,128,129)(H,146,147)(H4,101,102,105)(H4,103,104,106)/t52-,58+,60+,61+,62+,63+,64+,65+,66+,67+,68+,69+,70+,71+,72+,73+,74+,77+/m1/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0600 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharma AG
Curated by PDSP Ki Database
| |
Naunyn Schmiedebergs Arch Pharmacol 360: 488-99 (1999)
Article DOI: 10.1007/s002109900141
BindingDB Entry DOI: 10.7270/Q2Q23XTW |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 5
(Homo sapiens (Human)) | BDBM50051568
((3S,6S,9S,12R,15S,18S)-9-(4-Amino-butyl)-3-benzyl-...)Show SMILES CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc2ccccc2)NC1=O Show InChI InChI=1S/C44H56N8O7/c1-26(2)38-43(58)50-37(23-28-12-6-5-7-13-28)44(59)52(4)27(3)39(54)48-35(22-29-17-19-31(53)20-18-29)41(56)49-36(24-30-25-46-33-15-9-8-14-32(30)33)42(57)47-34(40(55)51-38)16-10-11-21-45/h5-9,12-15,17-20,25-27,34-38,46,53H,10-11,16,21-24,45H2,1-4H3,(H,47,57)(H,48,54)(H,49,56)(H,50,58)(H,51,55)/t27-,34-,35-,36+,37-,38-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0600 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharma AG
Curated by PDSP Ki Database
| |
Naunyn Schmiedebergs Arch Pharmacol 360: 488-99 (1999)
Article DOI: 10.1007/s002109900141
BindingDB Entry DOI: 10.7270/Q2Q23XTW |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 5
(Homo sapiens (Human)) | BDBM50051568
((3S,6S,9S,12R,15S,18S)-9-(4-Amino-butyl)-3-benzyl-...)Show SMILES CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc2ccccc2)NC1=O Show InChI InChI=1S/C44H56N8O7/c1-26(2)38-43(58)50-37(23-28-12-6-5-7-13-28)44(59)52(4)27(3)39(54)48-35(22-29-17-19-31(53)20-18-29)41(56)49-36(24-30-25-46-33-15-9-8-14-32(30)33)42(57)47-34(40(55)51-38)16-10-11-21-45/h5-9,12-15,17-20,25-27,34-38,46,53H,10-11,16,21-24,45H2,1-4H3,(H,47,57)(H,48,54)(H,49,56)(H,50,58)(H,51,55)/t27-,34-,35-,36+,37-,38-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0600 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharma
Curated by PDSP Ki Database
| |
Eur J Pharmacol 348: 311-20 (1998)
Article DOI: 10.1016/s0014-2999(98)00159-9
BindingDB Entry DOI: 10.7270/Q2MK6BF9 |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 2
(Homo sapiens (Human)) | BDBM82460
(L-Ser-L-Ala-L-Asn-L-Ser-L-Asn-L-Pro-L-Ala-L-Met-L-...)Show SMILES CSCCC(NC(=O)C(C)NC(=O)C1CCCN1C(=O)C(CC(N)=O)NC(=O)C(CO)NC(=O)C(CC(N)=O)NC(=O)C(C)NC(=O)C(N)CO)C(=O)NC(C)C(=O)N1CCC[C@H]1C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(O)=O)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCCN)C(=O)NC(C)C(=O)NCC(=O)N[C@H]1CSSC[C@@H](NC(=O)[C@@H](CO)NC(=O)[C@H](NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@@H](NC(=O)C(CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)C(Cc2ccccc2)NC(=O)C(Cc2ccccc2)NC(=O)C(CC(N)=O)NC(=O)C(CCCCN)NC1=O)[C@H](C)O)[C@H](C)O)C(O)=O |wU:211.220,130.221,wD:145.218,134.136,158.161,214.223,124.126,120.224,115.116,62.64,(6.16,1.45,;5.85,2.8,;5.24,3.82,;3.39,5.05,;1.54,6.16,;.92,4.93,;1.54,3.7,;3.39,2.59,;.92,2.46,;2.46,1.36,;.62,1.23,;3.39,,;5.85,60.59,;3.39,60.59,;5.5,59.26,;6.67,58.25,;5.85,58.03,;4.44,59.14,;5.03,57.91,;6.35,56.8,;4.87,56.68,;5.85,55.57,;6.56,54.33,;5.98,53.32,;6.71,53.19,;5.03,55.44,;5.5,54.21,;5.24,53.1,;4.5,52.98,;6.16,51.87,;6.75,50.64,;5.54,51.75,;6.08,50.51,;6.56,49.41,;5.5,49.28,;6.16,48.17,;6.67,46.94,;5.98,45.93,;6.71,45.8,;5.54,48.05,;5.85,46.82,;5.24,45.71,;4.5,45.59,;6.08,44.48,;5.4,44.35,;6.56,43.12,;6.56,42.01,;5.5,41.89,;5.03,40.66,;5.85,40.78,;6.35,39.43,;3.39,7.39,;5.24,6.28,;.92,8.62,;.62,9.86,;3.39,8.75,;.62,11.09,;2.46,9.98,;.62,12.32,;2.46,11.21,;4.31,11.43,;2.46,12.44,;.92,13.55,;1.54,14.78,;3.39,13.68,;.43,16.02,;.43,17.25,;1.91,16.14,;5.24,14.91,;5.85,13.89,;6.16,12.54,;6.16,11.3,;4.31,10.2,;6.16,10.07,;.92,18.48,;1.91,17.37,;.62,19.71,;.92,20.95,;2.46,19.84,;3.39,18.6,;3.39,17.59,;6.35,16.02,;4.87,16.23,;.92,22.18,;3.39,21.07,;.62,23.41,;.92,24.64,;2.46,23.53,;3.39,22.3,;5.85,21.28,;6.16,19.93,;5.85,18.82,;4.87,17.46,;6.35,17.25,;1.54,25.87,;3.39,24.76,;.92,27.11,;1.54,28.34,;3.39,27.23,;5.24,26,;5.85,24.98,;6.16,23.63,;5.85,22.52,;3.39,29.57,;5.24,28.46,;.92,30.8,;.92,32.03,;3.39,30.92,;1.54,33.27,;3.39,32.16,;1.54,34.5,;.92,35.73,;3.39,37.3,;3.39,35.85,;1.28,38.32,;.43,39.43,;.1,40.66,;.22,41.89,;2.33,43.46,;.7,44.48,;.06,45.59,;.1,46.82,;,48.05,;.92,46.94,;.22,49.28,;.62,48.17,;1.75,47.16,;.03,50.51,;,51.75,;.7,50.64,;.06,52.98,;.22,54.21,;.1,55.44,;1.28,54.33,;.43,56.68,;.92,55.57,;2.33,54.55,;.8,53.1,;1.85,51.96,;3.39,50.64,;2.46,51.75,;1.54,53.32,;.1,57.91,;.22,59.14,;.92,58.03,;.92,60.59,;1.28,59.26,;1.75,58.25,;3.39,57.01,;1.91,56.8,;3.39,55.44,;4.44,54.21,;3.76,53.1,;4.93,51.75,;5.4,50.51,;2.57,55.66,;3.39,54.43,;3.02,52.98,;2.28,53.19,;3.08,51.87,;4.06,50.85,;1.28,49.41,;1.85,48.27,;3.08,48.17,;3.39,46.82,;.8,45.71,;2.57,47.03,;2.46,48.05,;2.33,49.62,;3.7,52.09,;4.73,50.73,;4.44,49.28,;3.39,49.5,;4.31,48.27,;5.03,47.16,;3.02,45.59,;4.06,44.69,;5.5,43.25,;4.73,44.57,;3.76,45.71,;3.7,48.39,;4.21,46.94,;2.28,45.8,;1.54,45.93,;2.72,44.35,;4.44,43.12,;3.39,42.11,;3.39,40.66,;4.87,39.64,;4.21,40.78,;4.44,41.89,;2.04,44.57,;3.39,43.34,;2.33,42.23,;1.28,42.01,;1.75,41,;3.39,39.77,;5.5,38.32,;6.56,38.53,;.92,40.78,;1.91,39.55,;4.44,38.19,;3.39,38.41,;4.87,37.18,;5.85,36.07,;5.24,34.62,;5.24,33.39,;5.85,32.37,;.43,36.96,;.22,38.19,;1.91,37.09,;2.33,59.48,;2.57,58.12,;3.39,57.91,;.62,51.87,;1.37,50.85,;2.04,50.73,;.03,44.35,;.22,43.12,;1.28,43.25,)| Show InChI InChI=1S/C137H207N41O39S3/c1-69(154-113(194)82(37-19-22-47-138)159-115(196)85(40-25-50-149-136(145)146)160-118(199)87(44-45-106(188)189)163-116(197)86(41-26-51-150-137(147)148)164-130(211)101-43-27-52-177(101)133(214)72(4)156-114(195)88(46-54-218-7)158-110(191)71(3)155-129(210)100-42-28-53-178(100)134(215)95(61-104(144)186)171-126(207)96(65-180)172-124(205)93(59-102(142)184)165-111(192)70(2)153-112(193)80(141)64-179)109(190)152-63-105(187)157-98-67-219-220-68-99(135(216)217)174-127(208)97(66-181)173-132(213)108(74(6)183)176-125(206)91(57-77-33-15-10-16-34-77)170-131(212)107(73(5)182)175-119(200)84(39-21-24-49-140)161-122(203)92(58-78-62-151-81-36-18-17-35-79(78)81)168-121(202)90(56-76-31-13-9-14-32-76)166-120(201)89(55-75-29-11-8-12-30-75)167-123(204)94(60-103(143)185)169-117(198)83(162-128(98)209)38-20-23-48-139/h8-18,29-36,62,69-74,80,82-101,107-108,151,179-183H,19-28,37-61,63-68,138-141H2,1-7H3,(H2,142,184)(H2,143,185)(H2,144,186)(H,152,190)(H,153,193)(H,154,194)(H,155,210)(H,156,195)(H,157,187)(H,158,191)(H,159,196)(H,160,199)(H,161,203)(H,162,209)(H,163,197)(H,164,211)(H,165,192)(H,166,201)(H,167,204)(H,168,202)(H,169,198)(H,170,212)(H,171,207)(H,172,205)(H,173,213)(H,174,208)(H,175,200)(H,176,206)(H,188,189)(H,216,217)(H4,145,146,149)(H4,147,148,150)/t69?,70?,71?,72?,73-,74-,80?,82?,83?,84?,85?,86?,87?,88?,89?,90?,91+,92+,93?,94?,95?,96?,97+,98-,99+,100?,101-,107-,108+/m0/s1 | PDB
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0600 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharma AG
Curated by PDSP Ki Database
| |
Naunyn Schmiedebergs Arch Pharmacol 360: 488-99 (1999)
Article DOI: 10.1007/s002109900141
BindingDB Entry DOI: 10.7270/Q2Q23XTW |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 5
(Homo sapiens (Human)) | BDBM50051568
((3S,6S,9S,12R,15S,18S)-9-(4-Amino-butyl)-3-benzyl-...)Show SMILES CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc2ccccc2)NC1=O Show InChI InChI=1S/C44H56N8O7/c1-26(2)38-43(58)50-37(23-28-12-6-5-7-13-28)44(59)52(4)27(3)39(54)48-35(22-29-17-19-31(53)20-18-29)41(56)49-36(24-30-25-46-33-15-9-8-14-32(30)33)42(57)47-34(40(55)51-38)16-10-11-21-45/h5-9,12-15,17-20,25-27,34-38,46,53H,10-11,16,21-24,45H2,1-4H3,(H,47,57)(H,48,54)(H,49,56)(H,50,58)(H,51,55)/t27-,34-,35-,36+,37-,38-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0600 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharma AG
Curated by PDSP Ki Database
| |
Naunyn Schmiedebergs Arch Pharmacol 360: 488-99 (1999)
Article DOI: 10.1007/s002109900141
BindingDB Entry DOI: 10.7270/Q2Q23XTW |
More data for this
Ligand-Target Pair | |
Neuronal acetylcholine receptor subunit alpha-4
(Rattus norvegicus (Rat)) | BDBM50279402
(CHEMBL486511 | cis-2-(5-Bromopyridin-3-yl)-octahyd...)Show InChI InChI=1S/C11H14BrN3/c12-10-1-11(5-14-4-10)15-6-8-2-13-3-9(8)7-15/h1,4-5,8-9,13H,2-3,6-7H2/t8-,9+ | PDB
KEGG
UniProtKB/SwissProt
B.MOAD
GoogleScholar
AffyNet
| CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0600 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Abbott Laboratories
Curated by ChEMBL
| Assay Description
Displacement of [3H]cytisine from alpha4beta2 nicotinic acetylcholine receptor in rat brain minus cerebellum membrane |
J Med Chem 52: 4126-41 (2009)
Article DOI: 10.1021/jm900249k
BindingDB Entry DOI: 10.7270/Q2GT5P3R |
More data for this
Ligand-Target Pair | |
Somatostatin receptor type 5
(Homo sapiens (Human)) | BDBM50051568
((3S,6S,9S,12R,15S,18S)-9-(4-Amino-butyl)-3-benzyl-...)Show SMILES CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@H](C)N(C)C(=O)[C@H](Cc2ccccc2)NC1=O Show InChI InChI=1S/C44H56N8O7/c1-26(2)38-43(58)50-37(23-28-12-6-5-7-13-28)44(59)52(4)27(3)39(54)48-35(22-29-17-19-31(53)20-18-29)41(56)49-36(24-30-25-46-33-15-9-8-14-32(30)33)42(57)47-34(40(55)51-38)16-10-11-21-45/h5-9,12-15,17-20,25-27,34-38,46,53H,10-11,16,21-24,45H2,1-4H3,(H,47,57)(H,48,54)(H,49,56)(H,50,58)(H,51,55)/t27-,34-,35-,36+,37-,38-/m0/s1 | Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
antibodypedia
GoogleScholar
AffyNet
| Purchase
CHEMBL
PC cid
PC sid
UniChem
Similars
| Article
PubMed
| 0.0600 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Novartis Pharma
Curated by PDSP Ki Database
| |
Eur J Pharmacol 348: 311-20 (1998)
Article DOI: 10.1016/s0014-2999(98)00159-9
BindingDB Entry DOI: 10.7270/Q2MK6BF9 |
More data for this
Ligand-Target Pair | |
Search and Browse
